|
1
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Makker A and Goel MM: Tumor progression,
metastasis, and modulators of epithelial-mesenchymal transition in
endometrioid endometrial carcinoma: An update. Endocr Relat Cancer.
23:R85–R111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Donato R, Cannon BR, Sorci G, Riuzzi F,
Hsu K, Weber DJ and Geczy CL: Functions of S100 proteins. Curr Mol
Med. 13:24–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stewart RL and O'Connor KL: Clinical
significance of the integrin α6β4 in human malignancies. Lab
Invest. 95:976–986. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kiss B, Kalmar L, Nyitray L and Pal G:
Structural determinants governing S100A4-induced isoform-selective
disassembly of nonmuscle myosin II filaments. FEBS J.
283:2164–2180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dahlmann M, Kobelt D, Walther W, Mudduluru
G and Stein U: S100A4 in cancer metastasis: Wnt signaling-driven
interventions for metastasis restriction. Cancers. 8:pii: E59.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bresnick AR, Weber DJ and Zimmer DB: S100
proteins in cancer. Nat Rev Cancer. 15:96–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hua T, Liu S, Xin X, Cai L, Shi R, Chi S,
Feng D and Wang H: S100A4 promotes endometrial cancer progress
through epithelial-mesenchymal transition regulation. Oncol Rep.
35:3419–3426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deblois G and Giguere V: Functional and
physiological genomics of estrogen-related receptors (ERRs) in
health and disease. Biochim Biophys Acta. 1812:1032–1040. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ranhotra HS: The orphan estrogen-related
receptor alpha and metabolic regulation: New frontiers. J Recept
Signal Transduct Res. 35:565–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Madhavan S, Gusev Y, Singh S and Riggins
RB: ERRgamma target genes are poor prognostic factors in
Tamoxifen-treated breast cancer. J Exp Clin Cancer Res. 34:452015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Misawa A and Inoue S: Estrogen-Related
Receptors in Breast Cancer and Prostate Cancer. Front Endocrinol.
6:832015. View Article : Google Scholar
|
|
14
|
Gao M, Sun P, Wang J, Zhao D and Wei L:
Expression of estrogen receptor-related receptor isoforms and
clinical significance in endometrial adenocarcinoma. Int J Gynecol
Cancer. 16:827–833. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamamoto T, Mori T, Sawada M, Kuroboshi H,
Tatsumi H, Yoshioka T, Matsushima H, Iwasaku K and Kitawaki J:
Estrogen-related receptor-gamma regulates estrogen receptor-alpha
responsiveness in uterine endometrial cancer. Int J Gynecol Cancer.
22:1509–1516. 2012.PubMed/NCBI
|
|
16
|
Sun Y, Wang C, Yang H and Ma X: The effect
of estrogen on the proliferation of endometrial cancer cells is
mediated by ERRgamma through AKT and ERK1/2. Eur J Cancer Prev.
23:418–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang S, Zheng J, Huang Y, Song L, Yin Y,
Ou D, He S, Chen X and Ouyang X: Impact of S100A4 expression on
clinicopathological characteristics and prognosis in pancreatic
cancer: A meta-analysis. Dis Markers. 2016:81373782016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ling Z and Li R: Clinicopathological and
prognostic value of S100A4 expression in gastric cancer: A
meta-analysis. Int J Biol Markers. 29:e99–e111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stewart RL, Carpenter BL, West DS, Knifley
T, Liu L, Wang C, Weiss HL, Gal TS, Durbin EB, Arnold SM, et al:
S100A4 drives non-small cell lung cancer invasion, associates with
poor prognosis, and is effectively targeted by the FDA-approved
anti-helminthic agent niclosamide. Oncotarget. 7:34630–34642. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q,
Yang W, Zheng X, Tu K and Liu Q: miR-187-3p inhibits the metastasis
and epithelial-mesenchymal transition of hepatocellular carcinoma
by targeting S100A4. Cancer Lett. 381:380–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hernan R, Fasheh R, Calabrese C, Frank AJ,
Maclean KH, Allard D, Barraclough R and Gilbertson RJ: ERBB2
up-regulates S100A4 and several other prometastatic genes in
medulloblastoma. Cancer Res. 63:140–148. 2003.PubMed/NCBI
|
|
22
|
Kim TH, Kim HI, Soung YH, Shaw LA and
Chung J: Integrin (alpha6beta4) signals through Src to increase
expression of S100A4, a metastasis-promoting factor: Implications
for cancer cell invasion. Mol Cancer Res. 7:1605–1612. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang
F, Shao Z, Ding Y and Zhao L: LIM and SH3 protein 1 induces
TGFbeta-mediated epithelial-mesenchymal transition in human
colorectal cancer by regulating S100A4 expression. Clin Cancer Res.
20:5835–5847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huss JM, Garbacz WG and Xie W:
Constitutive activities of estrogen-related receptors:
Transcriptional regulation of metabolism by the ERR pathways in
health and disease. Biochim Biophys Acta. 1852:1912–1927. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deblois G, St-Pierre J and Giguere V: The
PGC-1/ERR signaling axis in cancer. Oncogene. 32:3483–3490. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giguere V: To ERR in the estrogen pathway.
Trends Endocrinol Metab. 13:220–225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun P, Sehouli J, Denkert C, Mustea A,
Könsgen D, Koch I, Wei L and Lichtenegger W: Expression of estrogen
receptor-related receptors, a subfamily of orphan nuclear
receptors, as new tumor biomarkers in ovarian cancer cells. J Mol
Med. 83:457–467. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Audet-Walsh E, Yee T, McGuirk S, Vernier
M, Ouellet C, St-Pierre J and Giguère V: Androgen-dependent
repression of errgamma reprograms metabolism in prostate cancer.
Cancer Res. 77:378–389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim JH, Choi YK, Byun JK, Kim MK, Kang YN,
Kim SH, Lee S, Jang BK and Park KG: Estrogen-related receptor gamma
is upregulated in liver cancer and its inhibition suppresses liver
cancer cell proliferation via induction of p21 and p27. Exp Mol
Med. 48:e2132016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huppunen J and Aarnisalo P: Dimerization
modulates the activity of the orphan nuclear receptor ERRgamma.
Biochem Biophys Res Commun. 314:964–970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Greschik H, Wurtz JM, Sanglier S, Bourguet
W, van Dorsselaer A, Moras D and Renaud JP: Structural and
functional evidence for ligand-independent transcriptional
activation by the estrogen-related receptor 3. Mol Cell. 9:303–313.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Audet-Walsh E and Giguere V: The multiple
universes of estrogen-related receptor α and γ in metabolic control
and related diseases. Acta Pharmacol Sin. 36:51–61. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eichner LJ, Perry MC, Dufour CR, Bertos N,
Park M, St-Pierre J and Giguère V: miR-378* mediates metabolic
shift in breast cancer cells via the PGC-1β/ERRγ transcriptional
pathway. Cell Metab. 12:352–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tiraby C, Hazen BC, Gantner ML and Kralli
A: Estrogen-related receptor gamma promotes
mesenchymal-to-epithelial transition and suppresses breast tumor
growth. Cancer Res. 71:2518–2528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ijichi N, Shigekawa T, Ikeda K,
Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T and Inoue S:
Estrogen-related receptor γ modulates cell proliferation and
estrogen signaling in breast cancer. J Steroid Biochem Mol Biol.
123:1–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jeon SY, Hwang KA and Choi KC: Effect of
steroid hormones, estrogen and progesterone, on epithelial
mesenchymal transition in ovarian cancer development. J Steroid
Biochem Mol Biol. 158:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Day RS, McDade KK, Chandran UR, Lisovich
A, Conrads TP, Hood BL, Kolli VS, Kirchner D, Litzi T and Maxwell
GL: Identifier mapping performance for integrating transcriptomics
and proteomics experimental results. BMC Bioinformatics.
12:2132011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pappa KI, Polyzos A, Jacob-Hirsch J,
Amariglio N, Vlachos GD, Loutradis D and Anagnou NP: Profiling of
discrete gynecological cancers reveals novel transcriptional
modules and common features shared by other cancer types and
embryonic stem cells. PLoS One. 10:e01422292015. View Article : Google Scholar : PubMed/NCBI
|
